Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Medtronic plc

Medtronic plc (MDT) Stock Overview

Explore Medtronic plc’s financial performance, market position, analyst ratings, and future outlook.

MDT●NYSE
HealthcareMedical - Devices
$92.09
$1.49(1.64%)
U.S. Market opens in 2h 5m

Medtronic plc (MDT)

Meyka AI Score

Z

Key Financials

Market Cap117.9B
P/E Ratio24.73
EPS (TTM)$5.53
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$87.71
3 Months$78.04
1 Year Target$89.75

MDT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Medtronic plc (NYSE: MDT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Medtronic plc's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MDT on the NYSE shows an RSI of 71.44, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $89.75 for the NYSE listing.

Key metrics behind Medtronic plc's NYSE-traded stock include a P/E ratio of 24.73 and a market capitalization of 117.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MDT on the NYSE.

Price Performance (NYSE: MDT)

1-Day Change
1.64%
5-Day Change
0.71%
1-Month Change
10.69%
3-Month Change
19.10%
6-Month Change
-6.50%
Year-to-Date (YTD) Change
-4.13%
1-Year Change
-0.78%
3-Year Change
12.97%
5-Year Change
-28.79%
All-Time (Max) Change
29276.67%

Contact Information

https://www.medtronic.com
353 1 438 1700
Building Two, Parkmore Business Park West, Galway, GA, H91 4K49

Company Facts

950,000 Employees
IPO DateMay 2, 1973
CountryIE
Actively Trading

Frequently Asked Questions